Can Fite Biopharma Ltd (ADR)

Stock Update (NYSE MKT:CANF): WHO Accepted “Piclidenoson” as Proposed New Generic Name for Can Fite Biopharma Ltd (ADR)’s Lead Drug Candidate CF101

Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today …

Corey Williams — July 29, 2015, 7:38 AM EDT

Stock Update (NYSE MKT:CANF): Can Fite Biopharma Ltd (ADR) Joins Israeli Life Sciences Delegation to Japan

Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today …

Corey Williams — July 23, 2015, 8:34 AM EDT

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts